Skip to article
Astra

Endocrinology

21-Hydroxylase Deficiency

Diagnose suspected 21-hydroxylase deficiency with properly timed 17-hydroxyprogesterone testing, urgently identify salt-wasting risk in newborns, and use cosyntropin steroid profiling and genotyping to resolve equivocal cases while guiding endocrine management and family counseling.

Clinical question: How should clinicians confirm 21-hydroxylase deficiency and identify patients at risk for salt-wasting adrenal crisis?

Immediate decisions

Identify salt-wasting risk before completing etiologic confirmation

Treat newborn evaluation as an adrenal-insufficiency risk assessment, not merely an abnormal screening result.

In a newborn with a screen suggestive of 21-hydroxylase deficiency, arrange urgent pediatric endocrinology assessment and obtain confirmatory serum 17-hydroxyprogesterone, serum electrolytes, and plasma renin activity. Electrolyte disturbance and renin elevation identify infants at risk for salt-wasting crisis. PubMedCongenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice GuidelinePubMedNewborn Screening for Congenital Adrenal Hyperplasia: Review of Factors Affecting Screening Accuracy

Classic 21-hydroxylase deficiency reduces cortisol synthesis and can reduce aldosterone synthesis; affected infants may develop life-threatening salt-wasting crisis. Female fetuses with classic disease may have virilization from androgen excess, but absence of ambiguous genitalia does not reduce concern for adrenal insufficiency in an infant with an abnormal screen. Wolters KluwerContemporary global management of 21-hydroxylase... : European Journal of EndocrinologyPubMedCongenital Adrenal Hyperplasia - Endotext - NCBI Bookshelf

If clinical concern for classic congenital adrenal hyperplasia is high, cosyntropin testing can be performed at 48 to 72 hours of life, and glucocorticoid treatment is often started while confirmatory results are pending. PubMedCongenital Adrenal Hyperplasia - Endotext - NCBI Bookshelf

Clinical branches after an abnormal newborn screen for congenital adrenal hyperplasia. PubMedCongenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice GuidelinePubMedNewborn Screening for Congenital Adrenal Hyperplasia: Review of Factors Affecting Screening AccuracyPubMedCongenital Adrenal Hyperplasia - Endotext - NCBI Bookshelf
FindingInterpretationNext action
Elevated serum 17-hydroxyprogesterone after positive screenSupports 21-hydroxylase deficiency; confirm biochemical phenotype. PubMedNewborn Screening for Congenital Adrenal Hyperplasia: Review of Factors Affecting Screening AccuracyAssess electrolytes and plasma renin activity; involve pediatric endocrinology. PubMedCongenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice GuidelinePubMedNewborn Screening for Congenital Adrenal Hyperplasia: Review of Factors Affecting Screening Accuracy
Electrolyte abnormalities and/or elevated plasma renin activityIdentifies risk for salt-wasting crisis from mineralocorticoid deficiency. PubMedNewborn Screening for Congenital Adrenal Hyperplasia: Review of Factors Affecting Screening AccuracyManage urgently as possible classic salt-wasting disease while endocrine evaluation proceeds. Wolters KluwerContemporary global management of 21-hydroxylase... : European Journal of EndocrinologyPubMedNewborn Screening for Congenital Adrenal Hyperplasia: Review of Factors Affecting Screening AccuracyPubMedCongenital Adrenal Hyperplasia - Endotext - NCBI Bookshelf
Only mildly increased 17-hydroxyprogesterone or unclear diagnosisScreening and baseline testing may not distinguish 21-hydroxylase deficiency from other enzyme defects. PubMedCongenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice GuidelinePubMedNewborn Screening for Congenital Adrenal Hyperplasia: Review of Factors Affecting Screening AccuracyPerform cosyntropin stimulation with a complete adrenal steroid profile; consider genotyping. PubMedCongenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice GuidelinePubMedNewborn Screening for Congenital Adrenal Hyperplasia: Review of Factors Affecting Screening AccuracyPubMedCongenital Adrenal Hyperplasia - Endotext - NCBI Bookshelf

Diagnostic testing

Use timed 17-hydroxyprogesterone testing and reflex cosyntropin profiling

Sampling conditions determine whether 17-hydroxyprogesterone is an effective diagnostic discriminator.

For symptomatic individuals past infancy, screen with baseline serum 17-hydroxyprogesterone collected before 8 AM and measured by liquid chromatography-tandem mass spectrometry. In menstruating patients, obtain the sample in the early follicular phase to reduce interpretive error from cycle-related steroid variation. PubMedCongenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline

A borderline baseline 17-hydroxyprogesterone should trigger a cosyntropin stimulation test with a complete adrenocortical steroid profile rather than a diagnosis based on one indeterminate value. This approach distinguishes 21-hydroxylase deficiency from other steroidogenic enzyme defects. PubMedCongenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline

A commonly used confirmatory protocol administers 250 micrograms of cosyntropin intravenously and measures serum 17-hydroxyprogesterone plus an adrenal steroid panel at baseline and 60 minutes. The stimulated panel is particularly important beyond the newborn period, when random 17-hydroxyprogesterone may be insufficiently elevated for accurate diagnosis of nonclassic disease. PubMedCongenital Adrenal Hyperplasia - Endotext - NCBI Bookshelf

When stimulated testing remains nondiagnostic, especially in a patient already receiving glucocorticoid therapy, obtain genotyping to clarify the diagnosis. In newborns, genotyping also helps interpret equivocal biochemical results and supports genetic counseling. PubMedCongenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice GuidelinePubMedNewborn Screening for Congenital Adrenal Hyperplasia: Review of Factors Affecting Screening Accuracy

Testing strategy by clinical setting. PubMedCongenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice GuidelinePubMedNewborn Screening for Congenital Adrenal Hyperplasia: Review of Factors Affecting Screening AccuracyPubMedCongenital Adrenal Hyperplasia - Endotext - NCBI Bookshelf
Clinical settingInitial testInterpretation and escalation
Positive newborn screenSerum 17-hydroxyprogesterone, electrolytes, and plasma renin activity. PubMedNewborn Screening for Congenital Adrenal Hyperplasia: Review of Factors Affecting Screening AccuracyConfirm biochemical disease and identify salt-wasting risk; use cosyntropin testing if 17-hydroxyprogesterone elevation is mild or diagnosis is unclear. PubMedCongenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice GuidelinePubMedNewborn Screening for Congenital Adrenal Hyperplasia: Review of Factors Affecting Screening Accuracy
Symptomatic patient past infancyPre-8 AM serum 17-hydroxyprogesterone by LC-MS/MS. PubMedCongenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice GuidelineIf borderline, obtain cosyntropin-stimulated complete adrenocortical profile. PubMedCongenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline
Persistent diagnostic uncertaintyCosyntropin test with baseline and 60-minute adrenal steroid measurements. PubMedCongenital Adrenal Hyperplasia - Endotext - NCBI BookshelfUse genotyping when stimulated findings are nondiagnostic, particularly during glucocorticoid therapy. PubMedCongenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline

Etiologic discrimination

Distinguish 21-hydroxylase deficiency from other steroidogenic disorders

The adrenal steroid pattern, mineralocorticoid phenotype, and sex-steroid precursor profile direct the next diagnostic step.

21-Hydroxylase deficiency is caused by pathogenic variants in CYP21A2 and produces impaired cortisol synthesis, accumulation of precursors including 17-hydroxyprogesterone, increased ACTH drive, and shunting toward adrenal androgen production. The biochemical consequence is central to both newborn screening and targeted confirmatory testing. ScienceDirectHypogonadism - an overview | ScienceDirect TopicsPubMedNewborn Screening for Congenital Adrenal Hyperplasia: Review of Factors Affecting Screening AccuracyPubMedCongenital Adrenal Hyperplasia - Endotext - NCBI Bookshelf

A complete post-cosyntropin steroid profile is required when 17-hydroxyprogesterone is indeterminate because elevated precursor concentrations are not unique to 21-hydroxylase deficiency. The Endocrine Society recommends this strategy specifically to differentiate 21-hydroxylase deficiency from other enzyme defects. PubMedCongenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline

Consider P450 oxidoreductase deficiency when genital or steroidogenic findings suggest congenital adrenal hyperplasia but electrolytes and mineralocorticoid function are normal, cortisol is nearly normal but has a poor ACTH-stimulated response, sex-steroid precursors are low, and progesterone and 17-hydroxyprogesterone have variable ACTH responses. This pattern should redirect testing toward comprehensive steroid profiling and genotype confirmation rather than assumed 21-hydroxylase deficiency. PubMedCongenital Adrenal Hyperplasia - Endotext - NCBI Bookshelf

Steroidogenic patterns that alter the diagnostic pathway. PubMedCongenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice GuidelinePubMedNewborn Screening for Congenital Adrenal Hyperplasia: Review of Factors Affecting Screening AccuracyPubMedCongenital Adrenal Hyperplasia - Endotext - NCBI Bookshelf
PatternDiagnostic implicationNext step
High 17-hydroxyprogesterone with cortisol deficiency and androgen excessCompatible with 21-hydroxylase deficiency. PubMedNewborn Screening for Congenital Adrenal Hyperplasia: Review of Factors Affecting Screening AccuracyPubMedCongenital Adrenal Hyperplasia - Endotext - NCBI BookshelfDefine classic versus nonclassic phenotype and assess mineralocorticoid status with electrolytes and plasma renin activity when relevant. PubMedNewborn Screening for Congenital Adrenal Hyperplasia: Review of Factors Affecting Screening Accuracy
Borderline 17-hydroxyprogesteroneDoes not reliably distinguish 21-hydroxylase deficiency from another enzyme defect. PubMedCongenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice GuidelineObtain cosyntropin-stimulated complete adrenocortical profile. PubMedCongenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline
Normal electrolytes/mineralocorticoid function, low sex-steroid precursors, poor cortisol response to ACTHSuggests P450 oxidoreductase deficiency. PubMedCongenital Adrenal Hyperplasia - Endotext - NCBI BookshelfUse comprehensive steroid profiling and genotype-directed confirmation. PubMedCongenital Adrenal Hyperplasia - Endotext - NCBI Bookshelf

Longitudinal care

Match therapy and surveillance to cortisol, mineralocorticoid, androgen, and reproductive consequences

Management aims to replace deficient hormones without excess glucocorticoid exposure.

Glucocorticoid replacement is the foundational treatment for 21-hydroxylase deficiency because the disorder is characterized by impaired cortisol synthesis and ACTH-driven adrenal androgen excess. In classic disease, intercurrent illness requires glucocorticoid stress dosing; acute illness poses adrenal-crisis risk particularly in salt-wasting 21-hydroxylase deficiency. NEJMPhase 3 Trial of Crinecerfont in Adult Congenital Adrenal ...Wolters KluwerContemporary global management of 21-hydroxylase... : European Journal of EndocrinologyScienceDirectHydrocortisone Release - an overview

For patients with classic salt-wasting disease who cannot take oral fludrocortisone, intravenous hydrocortisone at higher doses with sodium chloride can provide temporary mineralocorticoid effect; 20 mg hydrocortisone is described as equivalent to 0.1 mg 9-alpha-fludrocortisone. ScienceDirectHydrocortisone Release - an overview

Avoid chronic glucocorticoid overtreatment. Adult observational experience describes frequent obesity, adverse health metrics, reduced quality of life, and apparent glucocorticoid overtreatment; chronic therapy in women should use the minimum glucocorticoid amount that maintains an acceptable testosterone concentration, individualized to the patient. ScienceDirectAdrenal Crisis - an overview

In adult males, evaluate testicular masses or infertility with testicular ultrasonography because testicular adrenal rest tumors may be palpable or detectable only by ultrasound. These ACTH-responsive lesions can regress with adequate glucocorticoid therapy and ACTH suppression, whereas inadequate glucocorticoid control promotes growth. ScienceDirectHypogonadism - an overview | ScienceDirect Topics

For women pursuing pregnancy, optimize adrenal replacement before ovulation induction. A follicular-phase progesterone below 0.6 ng/mL (2 nmol/L) is associated with conception; described regimens include multiple daily hydrocortisone and/or prednisolone doses, with a 0.5 to 2 mg bedtime prednisolone dose used alongside daytime hydrocortisone or prednisolone. Ovulation induction may still be needed despite optimized replacement. ScienceDirectAdrenal Crisis - an overview

Selected longitudinal management decisions in 21-hydroxylase deficiency. ScienceDirectHypogonadism - an overview | ScienceDirect TopicsScienceDirectAdrenal Crisis - an overviewScienceDirectHydrocortisone Release - an overview
Clinical problemAssessmentManagement implication
Intercurrent illness in classic diseaseAssess need for glucocorticoid stress dosing and adrenal-crisis prevention. ScienceDirectHydrocortisone Release - an overviewProvide stress-dose glucocorticoid management; salt-wasting disease has greater adrenal-crisis risk than 11-beta-hydroxylase deficiency. ScienceDirectHydrocortisone Release - an overview
Inability to take oral fludrocortisoneAssess need for temporary mineralocorticoid coverage. ScienceDirectHydrocortisone Release - an overviewUse higher-dose IV hydrocortisone with sodium chloride; 20 mg hydrocortisone provides mineralocorticoid activity equivalent to 0.1 mg 9-alpha-fludrocortisone. ScienceDirectHydrocortisone Release - an overview
Male infertility or testicular lesionTesticular ultrasonography for testicular adrenal rest tumor. ScienceDirectHypogonadism - an overview | ScienceDirect TopicsOptimize glucocorticoid therapy and ACTH suppression because these lesions may regress. ScienceDirectHypogonadism - an overview | ScienceDirect Topics
Pregnancy planningMeasure follicular-phase progesterone. ScienceDirectAdrenal Crisis - an overviewTarget progesterone below 0.6 ng/mL (2 nmol/L) with individualized hydrocortisone/prednisolone therapy; consider standard ovulation induction if needed. ScienceDirectAdrenal Crisis - an overview

Emerging ACTH-directed therapy

Crinecerfont has been evaluated in a phase 3 trial in adults with congenital adrenal hyperplasia due to 21-hydroxylase deficiency, a population conventionally treated with glucocorticoid replacement. Its role should be considered within specialty-directed management rather than as a substitute for urgent glucocorticoid replacement in cortisol-deficient disease. NEJMPhase 3 Trial of Crinecerfont in Adult Congenital Adrenal ...

Counseling

Use genotyping when it changes diagnosis, counseling, or reproductive planning

Genetic confirmation is most useful when biochemical results are equivocal or family risk requires clarification.

21-Hydroxylase deficiency is an autosomal recessive disorder associated with pathogenic CYP21A2 variants. Use genotyping as a complement to biochemical testing when neonatal or stimulated steroid findings are equivocal and when genotype clarification will inform family counseling. ScienceDirectHypogonadism - an overview | ScienceDirect TopicsPubMedNewborn Screening for Congenital Adrenal Hyperplasia: Review of Factors Affecting Screening AccuracyPubMedCongenital Adrenal Hyperplasia - Endotext - NCBI Bookshelf

Prenatal treatment considerations require specialized expertise because affected female fetuses can undergo virilization from prenatal androgen excess. Establishing the familial molecular diagnosis is therefore clinically relevant before reproductive counseling or any prenatal management discussion. WileyPrenatal Treatment of Congenital Adrenal Hyperplasia ...PubMedCongenital Adrenal Hyperplasia - Endotext - NCBI Bookshelf

Situations in which CYP21A2 genotyping adds clinical value. PubMedCongenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice GuidelinePubMedNewborn Screening for Congenital Adrenal Hyperplasia: Review of Factors Affecting Screening Accuracy
SituationWhy genotype testing helps
Equivocal newborn biochemical findingsIt complements 17-hydroxyprogesterone testing and aids interpretation after newborn screening. PubMedNewborn Screening for Congenital Adrenal Hyperplasia: Review of Factors Affecting Screening Accuracy
Nondiagnostic cosyntropin-stimulated resultsIt may confirm the diagnosis, particularly when glucocorticoid treatment complicates biochemical interpretation. PubMedCongenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline
Family counseling and reproductive planningIt identifies the molecular basis of an autosomal recessive condition for familial risk assessment. ScienceDirectHypogonadism - an overview | ScienceDirect TopicsWileyPrenatal Treatment of Congenital Adrenal Hyperplasia ...

References

  1. Phase 3 Trial of Crinecerfont in Adult Congenital Adrenal ...www.nejm.org · www.nejm.org
  2. Congenital Adrenal Hyperplasia Due to 21-Hydroxylase ...www.nejm.org · www.nejm.org
  3. Adrenomedullary Dysplasia and Hypofunction in Patients ...www.nejm.org · www.nejm.org
  4. Congenital Adrenal Hyperplasiawww.nejm.org · www.nejm.org
  5. “Nonfunctional” Adrenal Tumors and the Risk for Incident ...www.acpjournals.org · www.acpjournals.org
  6. Future Directions in the Study and Management of ...www.acpjournals.org · www.acpjournals.org
  7. Inherited Forms of Mineralocorticoid Hypertensionwww.ahajournals.org · www.ahajournals.org
  8. Contemporary global management of 21-hydroxylase... : European Journal of Endocrinologyjournals.lww.com · journals.lww.com
  9. Hypogonadism - an overview | ScienceDirect Topicswww.sciencedirect.com · www.sciencedirect.com
  10. Adrenal Crisis - an overviewwww.sciencedirect.com · www.sciencedirect.com
  11. Hydrocortisone Release - an overviewwww.sciencedirect.com · www.sciencedirect.com
  12. 11-Ketotestosterone - an overviewwww.sciencedirect.com · www.sciencedirect.com
  13. Prenatal Treatment of Congenital Adrenal Hyperplasia ...onlinelibrary.wiley.com · onlinelibrary.wiley.com
  14. Long‐term health consequences of congenital adrenal ...onlinelibrary.wiley.com · onlinelibrary.wiley.com
  15. 21‐Hydroxylase Deficiency - NEWFIELD - 1997nyaspubs.onlinelibrary.wiley.com · nyaspubs.onlinelibrary.wiley.com
  16. Glucocorticoid replacement regimens for treating ...www.cochranelibrary.com · www.cochranelibrary.com
  17. Adrenal Insufficiency: Still a Cause of Morbidity and Death ...pediatrics.aappublications.org · pediatrics.aappublications.org
  18. Term Infant With Ambiguous Genitalia | NeoReviewsneoreviews.aappublications.org · neoreviews.aappublications.org
  19. Adrenal Insufficiency | Pediatrics In Reviewpedsinreview.aappublications.org · pedsinreview.aappublications.org
  20. Primary adrenal insufficiency in adults: When to suspect, how to diagnose and manage | Cleveland Clinic Journal of medicinewww.ccjm.org · www.ccjm.org
  21. Evaluation, Treatment, and Prevention of Vitamin D Deficiencywww.ccjm.org · www.ccjm.org
  22. Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guidelinepmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  23. Newborn Screening for Congenital Adrenal Hyperplasia: Review of Factors Affecting Screening Accuracypmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  24. Congenital Adrenal Hyperplasia - Endotext - NCBI Bookshelfwww.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov